Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jorge Gómez-Miragaya
Dual Fatty Acid Synthase and HER2 Signaling Blockade Shows Marked Antitumor Activity Against Breast Cancer Models Resistant to Anti-Her2 Drugs
PLoS ONE
Multidisciplinary
Related publications
Antitumor Activity of Phenethyl Isothiocyanate in HER2-positive Breast Cancer Models
BMC Medicine
Medicine
TAS0728, a Covalent-Binding, HER2-selective Kinase Inhibitor Shows Potent Antitumor Activity in Preclinical Models
Molecular Cancer Therapeutics
Cancer Research
Oncology
Dual HER2 Blockade: Preclinical and Clinical Data
Breast Cancer Research
Cancer Research
Oncology
ERBB3/HER2 Signaling Promotes Resistance to EGFR Blockade in Head and Neck and Colorectal Cancer Models
Molecular Cancer Therapeutics
Cancer Research
Oncology
Developing Anti-Her2 Vaccines: Breast Cancer Experience
International Journal of Cancer
Cancer Research
Oncology
EGFR and HER2 Signaling in Breast Cancer Brain Metastasis
Frontiers in Bioscience - Elite
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
The mTOR Inhibitor Rapamycin Synergizes With a Fatty Acid Synthase Inhibitor to Induce Cytotoxicity in ER/HER2-Positive Breast Cancer Cells
PLoS ONE
Multidisciplinary
Breast Cancer Stem Cells in HER2-negative Breast Cancer Cells Contribute to HER2-mediated Radioresistance and Molecular Subtype Conversion: Clinical Implications for Serum HER2 in Recurrent HER2-negative Breast Cancer
Oncotarget
Oncology
Dual Characteristics of Novel HER2 Kinase Domain Mutations in Response to HER2-Targeted Therapies in Human Breast Cancer
Clinical Cancer Research
Cancer Research
Oncology
